乙型脑炎疫苗致过敏性休克个案报道文献分析

目的：分析近10年来国内文献中，乙型脑炎（简称乙脑）有关接种疫苗致过敏性休克的个案报道，为减少乙脑计划免疫所出现的过敏性休克及相关处理提供参考。方法：采取适当检索策略，搜索中国学术期刊全文数据库（1994～2004年）中乙脑疫苗致过敏性休克的个案报道。分别从刊物、作者单位、乙脑疫苗生产厂家、患者年龄、性别、过敏史、接种次数、过敏性休克发生时间、治疗时间等多角度进行分析。结果：共获得文章34篇（36例）。1例为初种时发生，18例为复种时发生，17例接种次数不详。过敏性休克出现的平均时间为22．6min，最早1min，最晚60min。71．2％的过敏性休克伴随其他不良反应，以荨麻疹居多（57．1％）。36例中有5例死亡，其余均治愈，完全治愈所需时间最短为0．5h，最长为11d。结论：乙脑疫苗致过敏性休克的发生可能与免疫次数有关。在乙脑疫苗接种工作中，应该严格执行免疫程序，掌握过敏性休克的抢救知识，做好应对过敏性休克的准备。     

丹栀逍遥汤合并氟西汀治疗抑郁症临床研究

目的：比较观察丹栀逍遥汤加减合并氟西汀与单用氟西汀治疗抑郁症的疗效、不良反应及依从性。方法：将符合抑郁症中西医诊断标准的抑郁症患者随机分为两组,分别用丹栀逍遥汤合并氟西汀（n=36）和单用氟西汀（n=36）治疗,于用药前及用药2、4、6周时用HAMA、HAMD、CGI评定疗效并记录不良反应,比较两组疗效及依从性。结果：两组患者于治疗6周HAMD、HAMA、CGI评分均显著低于治疗前,两组间HAMD、HAMA评分在治疗4、6周差异显著（P〈0.01）。合并用药组有效率83.3%,显著优于单用组的有效率52.7%。结论：丹栀逍遥汤合并氟西汀治疗抑郁症疗效好,安全性高,依从性好。     

丹栀逍遥汤合并氟西汀治疗抑郁症临床研究

目的:比较观察丹栀逍遥汤加减合并氟西汀与单用氟西汀治疗抑郁症的疗效、不良反应及依从性。方法:将符合抑郁症中西医诊断标准的抑郁症患者随机分为两组,分别用丹栀逍遥汤合并氟西汀(n=36)和单用氟西汀(n=36)治疗,于用药前及用药2、4、6周时用HAMA、HAMD、CGI评定疗效并记录不良反应,比较两组疗效及依从性。结果:两组患者于治疗6周HAMD、HAMA、CGI评分均显著低于治疗前,两组间HAMD、HAMA评分在治疗4、6周差异显著(P<0.01)。合并用药组有效率83.3%,显著优于单用组的有效率52.7%。结论:丹栀逍遥汤合并氟西汀治疗抑郁症疗效好,安全性高,依从性好。     

清除补体对大鼠局灶性脑缺血的作用

目的观察抑制补体系统的活化或消除其影响抑制多形核中性粒细胞浸润,是否能减轻局灶性脑缺血损伤程度和神经功能缺损。方法采用局灶性脑缺血大鼠模型,用眼镜蛇毒因子(cobravenomfac-tor,CVF)消耗大鼠体内补体,于缺血第7天进行形态学观察,于缺血第1,4,7天测试实验动物的神经行为功能。结果与单纯缺血组比较,CVF处理组大鼠脑前囟前1.2mm和后0.8mm、1.8mm冠状平面梗死面积占同侧半球面积的百分数减小(29±3)%/(35±4)%,(32±5)/(45±8)%,(28±4)%/(38±4)%,达到非常显著性意义(t=3.13,4.30,4.47,P<0.01);缺血区域内中性粒细胞数均比单纯缺血组减少(3.4±1.4)/(5.3±2.0),达到显著性意义(t=2.35,P<0.05);CVF处理组的神经功能损害比单纯缺血组轻,达到显著性意义(P<0.05)或非常显著性意义(P<0.01)。结论清除体内补体对局灶性脑缺血损伤有保护作用,减轻神经功能缺损程度;局灶性脑缺血过程中补体系统活化,并对脑缺血损伤有贡献。     

200例乳腺癌患者的情感障碍及疏导

目的对乳腺癌患者进行情感障碍的疏导,从而提高乳腺癌患者的生活质量。方法随机抽取200例乳腺癌患者,通过问卷调查其情感障碍的情况,给予心理干预和疏导,并列表观察疏导后的效果。结果通过情感疏导,200例患者情感障碍均得以缓解获得良好疏导效果。结论每一次与患者的交流,患者都会感受到你细心的呵护。     

Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation--ease of use, acceptance, and organizational implications

Purpose: The Medtronic CareLink allows remote implantable device follow‐up. In this first European experience with CareLink, we assessed the ease of use of the system, the acceptance, and satisfaction of patients and clinicians. Methods: Patients implanted with biventricular defibrillators for more than 6 months received the CareLink monitor and were trained to perform home device interrogation and transmission. Patient and clinician experience and preference were evaluated through specific questionnaires. Results: Sixty‐seven patients were enrolled and were able to perform data transmissions during the 3‐month study duration. The overall duration of interrogation procedure was 7 ± 5 minutes, and frequently the procedure did not require the assistance of a caregiver. Patients reported a general preference for remote versus in‐clinic follow‐up and described a sense of reassurance created by the remote monitoring capability. In the centers, the review procedure was successful; its mean duration was 5 ± 2 minutes per transmission and the users indicated that the access and navigation of the review website were easy. At the end of the evaluation, the data available for remote review were judged complete and adequate to provide almost the same standard of care as that offered in traditional in‐clinic visit. In general, the remote monitoring was seen as a potential tool to improve the clinical management of patients with device. Conclusions: The ease of use, satisfaction, and acceptance of the CareLink Network in European clinical practice appears elevated both for patients and for clinicians.     

黄连消毒饮的药理实验研究

目的探讨黄连消毒饮的药理作用。方法随机将实验动物分成为受试组、空白对照组、标准对照组,记录、比较给药前后观察指标的变化。结果与空白对照组相比较,受试组有显著的疗效(P<0.01),有些方面优于标准对照组。结论黄连消毒饮有解热、镇痛、抗炎作用。